These empirical findings provide a mechanistic framework to explain the clinical observations that HCC patients with high levels of JARID1B in tissue samples have more chance of distant metastasis, a significantly shorter overall and disease-free survival. Here, KDM5B is linked to hepatocellular carcinoma.